Zevra Therapeutics, Inc. (ZVRA) Q3 2026 Earnings Name November 3, 2026 4:30 PM EST
Firm Individuals
Nichol Ochsner – Vice President of Investor Relations & Company Communications
Neil McFarlane – President, CEO & Director
Joshua Schafer – Chief Business Officer
Justin Renz – CFO & Treasurer
Convention Name Individuals
Kristen Kluska – Cantor Fitzgerald & Co., Analysis Division
Sumant Kulkarni – Canaccord Genuity Corp., Analysis Division
Truman Dunkley
Brandon Folkes – H.C. Wainwright & Co, LLC, Analysis Division
Jason Butler – Residents JMP Securities, LLC, Analysis Division
Eddie Hickman – Guggenheim Securities, LLC, Analysis Division
Kambiz Yazdi – BTIG, LLC, Analysis Division
Presentation
Operator
Good afternoon, and thanks for becoming a member of Zevra’s Third Quarter 2026 Monetary Outcomes and Company Replace Convention Name. [Operator Instructions]
In the present day’s name is being recorded and can be accessible by way of the Investor Relations part of the corporate’s web site later right this moment. The host for right this moment’s name is Nichol Ochsner, Zevra’s Vice President of Investor Relations and Company Communications.
Nichol Ochsner
Vice President of Investor Relations & Company Communications
Thanks, and welcome to those that are becoming a member of us. In the present day, we are going to present an summary of our latest accomplishments, adopted by a evaluation of our third quarter 2026 monetary outcomes. I encourage you to learn our monetary outcomes information launch, which was distributed this afternoon and is offered within the Buyers part of our web site.
Earlier than we start the decision, please notice that sure data shared right this moment will embrace forward-looking statements. Precise outcomes might differ materially from these acknowledged or implied by any forward-looking statements as a result of dangers and uncertainties related to Zevra’s enterprise.
Ahead-looking statements will not be guarantees or ensures and are inherently topic to dangers, uncertainties and different essential elements which will result in precise outcomes differing materially from the projections made and needs to be evaluated along with the Danger Elements part in our
